{"id":48804,"date":"2026-07-21T12:16:56","date_gmt":"2026-07-21T10:16:56","guid":{"rendered":"https:\/\/evropskasredstva.si\/media-center\/all-media\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/"},"modified":"2026-07-23T12:17:41","modified_gmt":"2026-07-23T10:17:41","slug":"eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals","status":"publish","type":"media_blog","link":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","title":{"rendered":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals"},"content":{"rendered":"\n<div class=\"wp-block-eu-skladi-container-block container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"content_outer\">\n<p class=\"wp-block-paragraph\"><strong>Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands at \u20ac27.5 million.   <\/strong><\/p>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div><\/div><\/div><\/div>\n\n<div class=\"wp-block-eu-skladi-container-block container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"content_outer\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\"><\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:50%\">\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1000\" height=\"435\" src=\"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg\" alt=\"\" class=\"wp-image-48759\" srcset=\"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg 1000w, https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399-300x131.jpg 300w, https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399-768x334.jpg 768w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"wp-element-caption\">EU funding for the development of critical technologies in biotechnology and pharmaceuticals; Photo: Magnific<\/figcaption><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:25%\"><\/div>\n<\/div>\n<\/div><\/div><\/div><\/div>\n\n<div class=\"wp-block-eu-skladi-container-block container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"content_outer\">\n<p class=\"wp-block-paragraph\">The project involves the establishment and upgrading of a state-of-the-art, nationally strategic research infrastructure for nuclear magnetic resonance technology using very high magnetic fields. It will be designed to support research, development, and production of critical technologies in the fields of biotechnology and the pharmaceutical industry. As part of the project, advanced research equipment will be purchased and installed. The project also covers the adaptation of facilities and the establishment of organisational and operational conditions for the infrastructure\u2019s operation, thereby providing research organisations and industrial users with open access to world-class research capabilities.  <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The project aims to reduce the strategic dependence of Slovenia and the European Union in the field of critical technology development. The new research infrastructure will support the development and production of technologies important to biotechnology companies and the pharmaceutical industry and will contribute to strengthening European research capabilities. By joining the European research consortium CERIC-ERIC, the project will strengthen international cooperation, knowledge transfer, and the competitiveness of the Slovenian research community.  <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The main objective of the project is to upgrade the Nuclear Magnetic Resonance Centre \u2013 the research infrastructure of the National Institute of Chemistry dedicated to nuclear magnetic resonance \u2013 with state-of-the-art equipment for the development of critical technologies and the training of highly qualified personnel. The project is based on collaboration between the National Institute of Chemistry as the lead partner and the University of Maribor, Faculty of Chemistry and Chemical Engineering, as a consortium partner. The partners will combine their cutting-edge research expertise, research infrastructure, and many years of experience, thereby making a significant contribution to the development of new technologies and their transfer to the economy.  <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The project, with a total value of \u20ac27.5 million, will be fully funded by the European Regional Development Fund. The beneficiaries of the funds are the National Institute of Chemistry and the University of Maribor, Faculty of Chemistry and Chemical Engineering. <\/p>\n<\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":10,"featured_media":48803,"parent":0,"template":"","class_list":["post-48804","media_blog","type-media_blog","status-publish","has-post-thumbnail","hentry","media_type-sporocila-za-javnost-en"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Sergeja Kari\u017e\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Evropska sredstva - Evropski strukturni in investicijski skladi\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva\" \/>\n\t\t<meta property=\"og:description\" content=\"Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-07-21T10:16:56+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-07-23T10:17:41+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/#listItem\",\"name\":\"Media Center\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/#listItem\",\"position\":2,\"name\":\"Media Center\",\"item\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/#listItem\",\"name\":\"Sporo\\u010dila za javnost\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/#listItem\",\"position\":3,\"name\":\"Sporo\\u010dila za javnost\",\"item\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#listItem\",\"name\":\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/#listItem\",\"name\":\"Media Center\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#listItem\",\"position\":4,\"name\":\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/#listItem\",\"name\":\"Sporo\\u010dila za javnost\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#organization\",\"name\":\"Evropska sredstva\",\"description\":\"Evropski strukturni in investicijski skladi\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/author\\\/sergeja\\\/#author\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/author\\\/sergeja\\\/\",\"name\":\"Sergeja Kari\\u017e\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#authorImage\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/app\\\/plugins\\\/ultimate-member\\\/assets\\\/img\\\/default_avatar.jpg\",\"width\":96,\"height\":96,\"caption\":\"Sergeja Kari\\u017e\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#webpage\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/\",\"name\":\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva\",\"description\":\"Ljubljana, 21 July 2026 \\u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/author\\\/sergeja\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/author\\\/sergeja\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/app\\\/uploads\\\/2026\\\/07\\\/2149994399.jpg\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#mainImage\",\"width\":1000,\"height\":435,\"caption\":\"A researcher at work in the lab\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#mainImage\"},\"datePublished\":\"2026-07-21T12:16:56+02:00\",\"dateModified\":\"2026-07-23T12:17:41+02:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/\",\"name\":\"Evropska sredstva\",\"description\":\"Evropski strukturni in investicijski skladi\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva","description":"Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands","canonical_url":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/evropskasredstva.si\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/#listItem","name":"Media Center"}},{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/#listItem","position":2,"name":"Media Center","item":"https:\/\/evropskasredstva.si\/en\/media-center\/","nextItem":{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/#listItem","name":"Sporo\u010dila za javnost"},"previousItem":{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/#listItem","position":3,"name":"Sporo\u010dila za javnost","item":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#listItem","name":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals"},"previousItem":{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/#listItem","name":"Media Center"}},{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#listItem","position":4,"name":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals","previousItem":{"@type":"ListItem","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/#listItem","name":"Sporo\u010dila za javnost"}}]},{"@type":"Organization","@id":"https:\/\/evropskasredstva.si\/en\/#organization","name":"Evropska sredstva","description":"Evropski strukturni in investicijski skladi","url":"https:\/\/evropskasredstva.si\/en\/"},{"@type":"Person","@id":"https:\/\/evropskasredstva.si\/en\/author\/sergeja\/#author","url":"https:\/\/evropskasredstva.si\/en\/author\/sergeja\/","name":"Sergeja Kari\u017e","image":{"@type":"ImageObject","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#authorImage","url":"https:\/\/evropskasredstva.si\/app\/plugins\/ultimate-member\/assets\/img\/default_avatar.jpg","width":96,"height":96,"caption":"Sergeja Kari\u017e"}},{"@type":"WebPage","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#webpage","url":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","name":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva","description":"Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/evropskasredstva.si\/en\/#website"},"breadcrumb":{"@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#breadcrumblist"},"author":{"@id":"https:\/\/evropskasredstva.si\/en\/author\/sergeja\/#author"},"creator":{"@id":"https:\/\/evropskasredstva.si\/en\/author\/sergeja\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#mainImage","width":1000,"height":435,"caption":"A researcher at work in the lab"},"primaryImageOfPage":{"@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#mainImage"},"datePublished":"2026-07-21T12:16:56+02:00","dateModified":"2026-07-23T12:17:41+02:00"},{"@type":"WebSite","@id":"https:\/\/evropskasredstva.si\/en\/#website","url":"https:\/\/evropskasredstva.si\/en\/","name":"Evropska sredstva","description":"Evropski strukturni in investicijski skladi","inLanguage":"en-US","publisher":{"@id":"https:\/\/evropskasredstva.si\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Evropska sredstva - Evropski strukturni in investicijski skladi","og:type":"article","og:title":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva","og:description":"Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands","og:url":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","article:published_time":"2026-07-21T10:16:56+00:00","article:modified_time":"2026-07-23T10:17:41+00:00","twitter:card":"summary_large_image","twitter:title":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva","twitter:description":"Ljubljana, 21 July 2026 \u2013 The Ministry of Local Self-Government, Cohesion and Regional Development has approved EU funding for the GIGA Nuclear Magnetic Resonance (GIGA NMR) project. The project will establish a state-of-the-art research infrastructure to develop critical technologies and strengthen research and innovation in biotechnology and pharmaceuticals. The European Regional Development Fund contribution stands"},"aioseo_meta_data":{"post_id":"48804","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-07-23 10:16:56","updated":"2026-07-23 10:31:45","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/evropskasredstva.si\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/evropskasredstva.si\/en\/media-center\/\" title=\"Media Center\">Media Center<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/\" title=\"Sporo\u010dila za javnost\">Sporo\u010dila za javnost<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tEU funding for the development of critical technologies in biotechnology and pharmaceuticals\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/evropskasredstva.si\/en\/"},{"label":"Media Center","link":"https:\/\/evropskasredstva.si\/en\/media-center\/"},{"label":"Sporo\u010dila za javnost","link":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/"},{"label":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals","link":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva\" \/>\n<meta property=\"og:url\" content=\"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Evropska sredstva\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/EUsredstva\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T10:17:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"435\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@mkrrSI\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/\",\"name\":\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/evropskasredstva.si\\\/app\\\/uploads\\\/2026\\\/07\\\/2149994399.jpg\",\"datePublished\":\"2026-07-21T10:16:56+00:00\",\"dateModified\":\"2026-07-23T10:17:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/app\\\/uploads\\\/2026\\\/07\\\/2149994399.jpg\",\"contentUrl\":\"https:\\\/\\\/evropskasredstva.si\\\/app\\\/uploads\\\/2026\\\/07\\\/2149994399.jpg\",\"width\":1000,\"height\":435,\"caption\":\"A researcher at work in the lab\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/sporocila-za-javnost-en\\\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Domov\",\"item\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Center\",\"item\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/media-center\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"EU funding for the development of critical technologies in biotechnology and pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/\",\"name\":\"Evropska sredstva\",\"description\":\"Evropski strukturni in investicijski skladi\",\"publisher\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#organization\",\"name\":\"Ministrstvo za kohezijo in regionalni razvoj\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/evropskasredstva.si\\\/app\\\/uploads\\\/2023\\\/03\\\/logo-e1678780179257.png\",\"contentUrl\":\"https:\\\/\\\/evropskasredstva.si\\\/app\\\/uploads\\\/2023\\\/03\\\/logo-e1678780179257.png\",\"width\":3232,\"height\":1695,\"caption\":\"Ministrstvo za kohezijo in regionalni razvoj\"},\"image\":{\"@id\":\"https:\\\/\\\/evropskasredstva.si\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/EUsredstva\\\/\",\"https:\\\/\\\/x.com\\\/mkrrSI\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva","og_url":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","og_site_name":"Evropska sredstva","article_publisher":"https:\/\/www.facebook.com\/EUsredstva\/","article_modified_time":"2026-07-23T10:17:41+00:00","og_image":[{"width":1000,"height":435,"url":"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@mkrrSI","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","url":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/","name":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals - Evropska sredstva","isPartOf":{"@id":"https:\/\/evropskasredstva.si\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg","datePublished":"2026-07-21T10:16:56+00:00","dateModified":"2026-07-23T10:17:41+00:00","breadcrumb":{"@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#primaryimage","url":"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg","contentUrl":"https:\/\/evropskasredstva.si\/app\/uploads\/2026\/07\/2149994399.jpg","width":1000,"height":435,"caption":"A researcher at work in the lab"},{"@type":"BreadcrumbList","@id":"https:\/\/evropskasredstva.si\/en\/media-center\/sporocila-za-javnost-en\/eu-funding-for-the-development-of-critical-technologies-in-biotechnology-and-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Domov","item":"https:\/\/evropskasredstva.si\/en\/"},{"@type":"ListItem","position":2,"name":"Media Center","item":"https:\/\/evropskasredstva.si\/en\/media-center\/"},{"@type":"ListItem","position":3,"name":"EU funding for the development of critical technologies in biotechnology and pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/evropskasredstva.si\/en\/#website","url":"https:\/\/evropskasredstva.si\/en\/","name":"Evropska sredstva","description":"Evropski strukturni in investicijski skladi","publisher":{"@id":"https:\/\/evropskasredstva.si\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/evropskasredstva.si\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/evropskasredstva.si\/en\/#organization","name":"Ministrstvo za kohezijo in regionalni razvoj","url":"https:\/\/evropskasredstva.si\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/evropskasredstva.si\/en\/#\/schema\/logo\/image\/","url":"https:\/\/evropskasredstva.si\/app\/uploads\/2023\/03\/logo-e1678780179257.png","contentUrl":"https:\/\/evropskasredstva.si\/app\/uploads\/2023\/03\/logo-e1678780179257.png","width":3232,"height":1695,"caption":"Ministrstvo za kohezijo in regionalni razvoj"},"image":{"@id":"https:\/\/evropskasredstva.si\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/EUsredstva\/","https:\/\/x.com\/mkrrSI"]}]}},"_links":{"self":[{"href":"https:\/\/evropskasredstva.si\/en\/wp-json\/wp\/v2\/media_blog\/48804","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/evropskasredstva.si\/en\/wp-json\/wp\/v2\/media_blog"}],"about":[{"href":"https:\/\/evropskasredstva.si\/en\/wp-json\/wp\/v2\/types\/media_blog"}],"author":[{"embeddable":true,"href":"https:\/\/evropskasredstva.si\/en\/wp-json\/wp\/v2\/users\/10"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/evropskasredstva.si\/en\/wp-json\/wp\/v2\/media\/48803"}],"wp:attachment":[{"href":"https:\/\/evropskasredstva.si\/en\/wp-json\/wp\/v2\/media?parent=48804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}